We are live on
!
Find out more
EARNEST Partners Portfolio holdings
AUM
$24.3B
1-Year Est. Return
34.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.65%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$17B
AUM Growth
+$279M
(+1.7%)
Cap. Flow
+$64.3M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
16.28%
Holding
1,199
New
4
Increased
99
Reduced
145
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parsons
PSN
|
+$51.1M |
| 2 |
HTLF
Heartland Financial USA, Inc.
HTLF
|
+$45.7M |
| 3 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$44.6M |
| 4 |
Emergent Biosolutions
EBS
|
+$42.4M |
| 5 |
Advanced Energy
AEIS
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$103M |
| 2 |
Sanmina
SANM
|
+$42.8M |
| 3 |
CS
Credit Suisse Group
CS
|
+$33M |
| 4 |
Myriad Genetics
MYGN
|
+$28.7M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$21.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.16% |
| 2 | Financials | 17.64% |
| 3 | Industrials | 17.28% |
| 4 | Healthcare | 12.82% |
| 5 | Consumer Discretionary | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Pfizer
PFE
$144B
| $103K | ﹤0.01% |
2,641
| – | – |
|
277
Salesforce
CRM
$149B
| $102K | ﹤0.01% |
419
| – | – |
|
278
MGP Ingredients
MGPI
$400M
| $101K | ﹤0.01% |
1,500
| – | – |
|
279
Thermo Fisher Scientific
TMO
$214B
| $100K | ﹤0.01% |
199
| – | – |
|
280
AT&T
T
$169B
| $99K | ﹤0.01% |
4,569
| – | – |
|
281
UFP Technologies
UFPT
$2B
| $98K | ﹤0.01% |
1,700
| – | – |
|
282
Walmart Inc
WMT
$900B
| $97K | ﹤0.01% |
2,061
| – | – |
|
283
Coca-Cola
KO
$380B
| $96K | ﹤0.01% |
1,777
| – | – |
|
284
PepsiCo
PEP
$195B
| $96K | ﹤0.01% |
645
| – | – |
|
285
AbbVie
ABBV
$465B
| $95K | ﹤0.01% |
847
| – | – |
|
286
Abbott
ABT
$187B
| $95K | ﹤0.01% |
819
| – | – |
|
287
Sherwin-Williams
SHW
$87.4B
| $93K | ﹤0.01% |
342
| – | – |
|
288
Carriage Services
CSV
$648M
| $92K | ﹤0.01% |
2,500
| – | – |
|
289
Merck
MRK
$326B
| $92K | ﹤0.01% |
1,183
-57
| -5% | -$4.24K |
|
290
Eli Lilly
LLY
$1.09T
| $91K | ﹤0.01% |
398
| – | – |
|
291
Accenture
ACN
$101B
| $90K | ﹤0.01% |
306
| – | – |
|
292
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.2B
| $90K | ﹤0.01% |
1,220
| – | – |
|
293
Broadcom
AVGO
$1.81T
| $89K | ﹤0.01% |
1,860
| – | – |
|
294
Nike
NKE
$63.9B
| $88K | ﹤0.01% |
569
| – | – |
|
295
Escalade
ESCA
$275M
| $87K | ﹤0.01% |
3,810
| – | – |
|
|
QADA
296
DELISTED
QAD Inc.
QADA
| $87K | ﹤0.01% |
1,001
| – | – |
|
297
NextEra Energy
NEE
$186B
| $84K | ﹤0.01% |
1,144
| – | – |
|
298
iShares MSCI India ETF
INDA
$6.84B
| $83K | ﹤0.01% |
1,874
| – | – |
|
299
McDonald's
MCD
$194B
| $83K | ﹤0.01% |
358
| – | – |
|
300
Medtronic
MDT
$111B
| $82K | ﹤0.01% |
657
| – | – |
|
Similar funds
JG
SC
CS
AF
EARNEST Partners's Q2 2021 Portfolio in Review
As of Q2 2021, EARNEST Partners held 1,199 positions worth $17B, up 1.7% from $16.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 1.2%. EARNEST Partners opened 4 new positions and exited 10, leaving the 1,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
- EARNEST Partners's largest Q2 2021 buy was Digi International: 728,802 shares worth $14.7M.
- EARNEST Partners added most to Parsons in Q2 2021, an estimated $51.1M increase.
- EARNEST Partners's biggest Q2 2021 reduction was Darling Ingredients, cutting an estimated $103M.
- EARNEST Partners fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $6.27M.
- EARNEST Partners's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
- EARNEST Partners opened 4 new positions and closed 10 in Q2 2021.
- EARNEST Partners's portfolio value rose 1.7% quarter-over-quarter to $17B.
Based on EARNEST Partners's 13F filing for Q2 2021, filed 16 Aug 2021.